B.C. company expands antibody research, production facilities for second time
A Vancouver-based company that helped develop the first antibody therapy treatment for COVID-19 is expanding its research and development capacity as it continues to pursue world-leading new medicines, says Innovation Minister Francois-Philippe Champagne.
AbCellera Biologics announced a $701-million federal and British Columbia-backed infrastructure project Wednesday that will increase the overall scope of a manufacturing plant, which has been in the works since 2020, to facilitate clinical trials and help deliver antibody medicines to patients.
The federal government gave AbCellera $176 million toward the manufacturing plant and announced another $225 million Wednesday for the research and clinical trial projects, Champagne told a news conference at AbCellera's headquarters.
The B.C. government is providing $75 million.
“We're building a global champion,” Champagne said. “I think (of) this morning as one of the historic moments where we build a Canadian champion that we can all be proud of as Canadians.”
AbCellera senior vice-president Murray McCutcheon said the company's expansion project, which is described as a biotech campus, will be able to take research on antibody therapies from early ideas through to clinical trials.
Vaccines trigger the body to make antibodies to prevent or limit an infection before exposure, and antibody therapies are given to help a body fight off an infection after it has already started.
AbCellera partnered with drug giant Eli Lilly in 2020 to develop Bamlanivimab, which was authorized for use less than a year after the first case of COVID-19 was discovered.
While AbCellera helped discover that therapy, the doses were manufactured outside of Canada.
The new manufacturing plant is under construction now and is set to be producing antibody therapies for clinical trials starting next year.
B.C. Premier David Eby said the expansion project will create more than 400 jobs, while ensuring world-leading medicines are developed in Canada for Canadians and people globally.
“This means new training for British Columbians, this investment today,” he said. “It means access to frontline treatment through clinical trials. It means that when intellectual property is developed through research here that the financial benefits stay in our province and in our country.”
The expansion of the medical research also means if there is another global pandemic “we have the capacity here in our province and our country to support Canadians and British Columbians,” Eby said.
McCutcheon said the first focus will be on antibody therapies for use against cancer and autoimmune diseases.
The company was founded in 2012 and currently has about 500 employees.
This report by The Canadian Press was first published May 24, 2023.
CTVNews.ca Top Stories
DEVELOPING 122 active wildfires burning across Canada, 32 considered 'out of control'
The 2024 wildfire season has begun, and it's shaping up to follow last year's unprecedented destruction in kind, with thousands of square kilometres already consumed.
B.C. parents sentenced to 15 years for death of 6-year-old boy
A British Columbia Supreme Court judge has sentenced the mother and stepfather of a six-year-old boy who died from blunt-force trauma in 2018 to 15 years in prison.
Veteran TSN sportscaster Darren Dutchyshen has died
Veteran TSN broadcaster Darren 'Dutch' Dutchyshen, one of Canada’s best-known sports journalists, has died. He was 57. His family says 'he passed as he was surrounded by his closest loved ones.'
'More aggressive': Tocchet shifts lineups as Canucks get ready to take on Oilers in Vancouver
As the Canucks prepare to take on the Oilers for Game 5, Vancouver head coach Rick Tocchet is making changes to the team's lineup.
Think twice before sharing 'heartbreaking' social media posts, RCMP warn
Mounties in B.C. are urging people to think twice before sharing "heartbreaking posts" on social media.
Police issue Canada-wide warrant for Regina homicide suspect
Police have issued a Canada-wide warrant for a man wanted in a homicide which occurred in Regina on May 12.
Trudeau calls New Brunswick's Conservative government a 'disgrace' on women's rights
Prime Minister Justin Trudeau assailed New Brunswick's premier and other conservative leaders on Thursday, calling out the provincial government's position on abortion, LGBTQ youth and climate change.
Kevin Spacey receives star support as he fights to get his career back
Kevin Spacey is pushing back on the 'rush to judgment' against him and is being backed by some big names as he seeks to reclaim his acting career.
Speaker cuts ties with Sask. Party, alleges he faced threats, harassment from gov't MLAs
The Speaker of the Saskatchewan Legislature Randy Weekes has severed ties with the Sask. Party after accusing some members of harassment and intimidation tactics, including a situation he claimed saw the Government House Leader bring a hunting rifle to the legislative building.